1. Crosstalk between oncogenic MYC and noncoding RNAs in cancer
   Rongfu Tu et al, 2021, Seminars in Cancer Biology CrossRef
2. MiRNA:RBP Interplay as a Key Regulatory Element in Health and Disease
   Marcos G. Teneche et al, 2020, Proceedings of the Singapore National Academy of Science CrossRef
3. Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma
   Jessica L. Bell et al, 2020, International Journal of Molecular Sciences CrossRef
4. RNA binding protein HuD promotes autophagy and tumor stress survival by suppressing mTORC1 activity and augmenting ARL6IP1 levels
   Kausik Bishayee et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
5. The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer
   Yiyi Ji et al, 2023, Nature Communications CrossRef
6. Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
   Omidvar Rezaei et al, 2021, Frontiers in Oncology CrossRef
7. MYCN in Neuroblastoma: “Old Wine into New Wineskins”
   Maria Braoudaki et al, 2021, Diseases CrossRef
8. IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
   Sven Hagemann et al, 2023, Molecular Cancer CrossRef
9. The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
   Danny Misiak et al, 2021, Frontiers in Oncology CrossRef
10. The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
    Renata Gruszka et al, 2018, International Journal of Molecular Sciences CrossRef
11. Loss of Lamin A leads to the nuclear translocation of AGO2 and compromised RNA interference
    Vivian Lobo et al, 2024, Nucleic Acids Research CrossRef
12. Current Challenges in the Management of Neuroblastoma
    Duncan Ayers, 2019, Neuroblastoma CrossRef